Katherine Stueland is the President and CEO of GeneDx, a medical genetic testing company that focuses on whole genome and whole exome sequencing.
Katherine Stueland is the President and CEO of GeneDx, a medical genetic testing company that focuses on whole genome and whole exome sequencing. She leads a $2.6 billion business with $302 million in annual revenue. Stueland has built her career around delivering breakthrough healthcare technologies with a patient-centric approach.
Full founder directory · Investor directory · Company funding database · Fundraising library